Correlation Between AnaptysBio and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and AN2 Therapeutics, you can compare the effects of market volatilities on AnaptysBio and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and AN2 Therapeutics.
Diversification Opportunities for AnaptysBio and AN2 Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AnaptysBio and AN2 is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of AnaptysBio i.e., AnaptysBio and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between AnaptysBio and AN2 Therapeutics
Given the investment horizon of 90 days AnaptysBio is expected to generate 1.04 times more return on investment than AN2 Therapeutics. However, AnaptysBio is 1.04 times more volatile than AN2 Therapeutics. It trades about 0.09 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 1,500 in AnaptysBio on October 20, 2024 and sell it today you would earn a total of 85.00 from holding AnaptysBio or generate 5.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AnaptysBio vs. AN2 Therapeutics
Performance |
| Timeline |
| AnaptysBio |
| AN2 Therapeutics |
AnaptysBio and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AnaptysBio and AN2 Therapeutics
The main advantage of trading using opposite AnaptysBio and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |